Monday, June 29, 2015

Aerie Pharmaceuticals Bolsters Board

Irvine-based Aerie Pharmaceuticals said today that it has named two new members of its board of directors. The company--which is developing treatments for glaucoma--said it has added Julie McHugh and Michael M. du Toit to its board. McHugh was previously COO of Endo Health Solutions, and also served as an executive at Nora Therapeutics, Johnson & Johnson, and Centocor, and sits on the boards of EPIRUS Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., New Xellia Group A/S, Trevena Pharmaceuticals, Inc., and ViroPharma, among other organizations. du Toit is President at Everyday Health, and also has served at Publicis Healthcare Communications Group, Digitas Health, Razorfish Health, Grey Advertising, TMX Communications, and Ventiv Health Communications, along with Glaxo and Boehringer Ingelheim.